Mitchell Chan - 01 Dec 2021 Form 3 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
Christopher R. Sullivan, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
01 Dec 2021
Net transactions value
$0
Form type
3
Filing time
03 Dec 2021, 19:42:36 UTC
Next filing
15 Jun 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.